von Willebrand factor variant p.Arg924Gln marks an allele associated with reduced von Willebrand factor and factor VIII levels
Article first published online: 21 MAY 2010
DOI: 10.1111/j.1538-7836.2010.03927.x
© 2010 International Society on Thrombosis and Haemostasis
Additional Information
How to Cite
HICKSON, N., HAMPSHIRE, D., WINSHIP, P., GOUDEMAND, J., SCHNEPPENHEIM, R., BUDDE, U., CASTAMAN, G., RODEGHIERO, F., FEDERICI, A. B., JAMES, P., PEAKE, I., EIKENBOOM, J., GOODEVE, A. and ON BEHALF OF THE MCMDM-1VWD and ZPMCB-VWD STUDY GROUPS (2010), von Willebrand factor variant p.Arg924Gln marks an allele associated with reduced von Willebrand factor and factor VIII levels. Journal of Thrombosis and Haemostasis, 8: 1986–1993. doi: 10.1111/j.1538-7836.2010.03927.x
Publication History
- Issue published online: 6 SEP 2010
- Article first published online: 21 MAY 2010
- Received 25 November 2009, accepted 12 May 2010
Keywords:
- ABO blood group;
- factor VIII;
- founder effect;
- R924Q;
- type 1 von Willebrand disease;
- von Willebrand factor
Summary. Background: von Willebrand factor (VWF) variant c.2771G>A; p.R924Q has been described as a benign polymorphism or a possible marker for a null allele and been associated with mild bleeding phenotypes. It was identified in several patients in recent type 1 von Willebrand disease (VWD) studies. Objectives: To determine whether the p.R924Q allele contributes to reduced VWF levels and type 1 VWD. Methods: One thousand one hundred and fifteen healthy controls and 148 index cases from the MCMDM-1VWD study were genotyped for c.2771G>A; VWF and FVIII levels were analyzed in ABO blood group stratified individuals and the p.R924Q variant was expressed in 293 EBNA cells. Results: c.2771G>A was present in six index cases, five of whom had a second VWF variant which probably contributed to the phenotype. A common core haplotype identified in families, which included the rare G allele of c.5843-8C>G, was present in the majority of 35 c.2771G>A heterozygous controls. c.2771G>A contributed about 10% variance in VWF and FVIII levels in controls and 35% variance when co-inherited with blood group O. Recombinant p.R924Q VWF had no effect on in vitro expression and heterozygous family members had normal VWF-FVIII binding and normal clearance of VWF and FVIII. Conclusions: The allele bearing c.2771A leads to reductions in VWF and FVIII levels particularly in combination with blood group O. Its inheritance alone may be insufficient for VWD diagnosis, but it appears to be associated with a further VWF level reduction in individuals with a second VWF mutation and it contributes to population variance in VWF and FVIII levels.

1538-7836/asset/olbannerleft.gif?v=1&s=77e14c4c55f90ae6eb6fec99ac201108f7c92510)
1538-7836/asset/olbannerright.gif?v=1&s=87cd273ca1fd9dc5d95b1da3d90fa3ee7637f329)
